カテゴリー： Grand View Research, 世界, 医療/バイオ

神経科学のグローバル市場2023-2030：機器、消耗品

◆英語タイトル：Neuroscience Market Size, Share & Trends Analysis Report By Component (Instruments, Consumables), By Technology (Neuro-Microscopy, Brain Imaging), By End-user (Hospitals, Diagnostic Laboratories), And Segment Forecasts, 2023 - 2030

Grand View Researchが発行した調査報告書（GRV23SEP020）◆商品コード：GRV23SEP020
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2023年8月
◆ページ数：117
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

神経科学市場の成長と動向
Grand View Research, Inc.の最新レポートによると、神経科学の世界市場規模は2030年までに652億米ドルに達し、2023年から2030年までの年平均成長率は5.56%で成長すると予測されています。この成長は、慢性神経疾患の発生率の増加に起因しています。脳卒中、てんかん、多発性硬化症、認知症、パーキンソン病、その他の疾患は、高い神経疾患負担の主な原因となっています。世界脳卒中機構（WSO）によると、年間1,220万件以上の脳卒中発症が報告されています。また、世界全体では、25歳以上の4人に1人が一生のうちに脳卒中にかかると推定されています。このように、脳卒中の有病率の増加は、脳卒中に関連する機器の需要を促進し、市場の成長を促すと予測されています。

さらに、吸引カテーテルや血栓回収装置など、斬新で技術的に高度な神経血管インターベンション装置を発売するための研究開発（R&D）支援に対するメーカーの関心も高まっています。インフィニティ・ニューロ社は、2023年1月、吸引カテーテルについて、出血性脳梗塞および虚血性脳梗塞の患者に対する治療薬として、欧州の規制当局からCEマークの承認を取得しました。このように、さまざまな神経疾患の診断や治療に使用される新しいデバイスの承認と発売が、最近、最前線で行われています。ここ数年の人工知能(AI)やソフトウェア開発の技術的進歩により、ヘルスケア分野、特に診断・研究分野でソフトウェアやサービスの需要が高まっています。

ソフトウェアは、良好な画質を提供し、治療失敗のリスクを最小限に抑えるための健康管理を容易にする上で重要な役割を果たしています。2023年2月、Hyperfine, Inc.は、アップグレードしたAI搭載ソフトウェアの米国FDA認可を取得しました。このソフトウェア認可は、脳の拡散強調画像（DWI）の画質を向上させるソフトウェアの使用を意味します。今後数年間、新しいソフトウェアの研究開発を後押しし、市場の成長をサポートすると予想されます。さらに、大手企業は市場での地位を強化するために企業を買収しています。この戦略により、企業は能力を高め、製品ポートフォリオを拡大し、能力を向上させることができます。例えば、2022年11月、Bruker Corp.はInscopix,,Inc.を買収。この買収により、インビボ脳機能イメージング・ポートフォリオにおけるブルカーの地位が強化され、市場成長が促進されました。

神経科学市場レポートハイライト

- コンポーネント別では、機器セグメントが2022年の収益シェア64.71%で市場を支配しました。この優位性は、診断や外科手術の際に器具の使用が増加していることに起因しています。

- 技術面では、脳画像セグメントが2022年に25.19%のシェアで業界を支配しました。これは、神経疾患の診断と治療における脳画像の重要性に対する医師の意識の高まりによるものです。

- 診断ラボのエンドユーザーセグメントは、2022年に42.04%の収益シェアで業界を支配しました。神経科学疾患の診断に従事する診断センターの増加が、MRIやCTスキャンなどの機器需要を促進すると予測されます。

- 北米が2022年に31.42%の最大収益シェアを獲得。技術の進歩、政府による高額の投資、先進的な神経科学機器の採用がこの地域の市場成長を促進すると予測されます。

- 戦略的パートナーシップ、研究開発への大規模な投資、新製品または製品改良の開発は、製品のリーチを拡大し、多様な地域での利用可能性を向上させるために市場プレーヤーが採用する主要な戦略です。

第1章．調査手法＆範囲
第2章．エグゼクティブサマリー
第3章．神経科学市場：市場変動・動向・範囲
第4章．神経科学市場：成分別予測＆動向分析
第5章．神経科学市場：技術別予測＆動向分析
第6章．神経科学市場：エンドユーザー別予測＆動向分析
第7章．神経科学市場：地域別予測＆動向分析
第8章．競争状況

❖ レポートの目次 ❖

Table of Content

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Component
1.1.2. Technology
1.1.3. End-user
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. Component outlook
2.2.3. Technology outlook
2.2.4. End-user outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Neuroscience Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising disease burden of brain-associated disorders
3.2.1.2. Advancement in research for translation of neuroscience to neuro-technology
3.2.1.3. Increasing investments by the government for R&D activities
3.2.2. Market restraint analysis
3.2.2.1. High cost associated with neuroscience devices
3.2.2.2. Strict government regulations
3.3. Neuroscience Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Covid-19 Impact Analysis
Chapter 4. Neuroscience Market: Component Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Instruments
4.1.2. Consumables
4.1.3. Software & Services
4.2. Component Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global Surgical Refractor Market by Component Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. Instruments
4.5.1.1. Instruments market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Consumables
4.5.2.1. Consumables market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Software & Services
4.5.3.1. Software & Services market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Neuroscience Market: Technology Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Brain Imaging
5.1.2. Neuro-Microscopy
5.1.3. Stereotaxic Surgeries
5.1.4. Neuro-Proteomic Analysis
5.1.5. Neuro-Cellular Manipulation
5.1.6. Others
5.2. Product Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Global Refractive Surgery Devices Market by Product Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
5.5.1. Brain Imaging
5.5.1.1. Brain imaging market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Neuro-Microscopy
5.5.2.1. Neuro microscopy market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Stereotaxic Surgeries
5.5.3.1. Stereotaxic surgeries market estimates and forecast 2018 to 2030 (USD Million)
5.5.4. Neuro-Proteomic Analysis
5.5.4.1. Neuro-proteomic Analysis market estimates and forecast 2018 to 2030 (USD Million)
5.5.5. Neuro-Cellular Manipulation
5.5.5.1. Neuro-cellular Manipulation market estimates and forecast 2018 to 2030 (USD Million)
5.5.6. Others
5.5.6.1. Other market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Neuroscience: End-user Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Diagnostic Laboratories
6.1.3. Research and Academic Institute
6.2. End-user Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. Global Refractive Surgery Devices Market by End-user Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Diagnostic laboratories
6.5.2.1. Diagnostic laboratories market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Research and Academic Institute
6.5.3.1. Research and academic institute market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Neuroscience Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2018 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2023 to 2030
7.5. North America
7.5.1. U.S.
7.5.1.1. U.S. market estimates and forecast, 2018 – 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Canada market estimates and forecast, 2018 – 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. UK market estimates and forecast, 2018 – 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Germany market estimates and forecast, 2018 – 2030 (USD Million)
7.6.3. France
7.6.3.1. France market estimates and forecast, 2018 – 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Italy market estimates and forecast, 2018 – 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Spain market estimates and forecast, 2018 – 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Norway market estimates and forecast, 2018 – 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Sweden market estimates and forecast, 2018 – 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Denmark market estimates and forecast, 2018 – 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Japan market estimates and forecast, 2018 – 2030 (USD Million)
7.7.2. China
7.7.2.1. China market estimates and forecast, 2018 – 2030 (USD Million)
7.7.3. India
7.7.3.1. India market estimates and forecast, 2018 – 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Australia market estimates and forecast, 2018 – 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. South Korea market estimates and forecast, 2018 – 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Thailand market estimates and forecast, 2018 – 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Brazil market estimates and forecast, 2018 – 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Mexico market estimates and forecast, 2018 – 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Argentina market estimates and forecast, 2018 – 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. South Africa market estimates and forecast, 2018 – 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Saudi Arabia market estimates and forecast, 2018 – 2030 (USD Million)
7.9.3. UAE
7.9.3.1. UAE market estimates and forecast, 2018 – 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Kuwait market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2022
8.3.4. Carl Zeiss AG
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Danaher Corporation
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. GE Healthcare
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Siemens Healthcare Private Limited
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Koninklijke Philips N.V.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Canon Inc.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. B. Braun SE
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Medtronic
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Stryker
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Boston Scientific Corporation
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. ABBOTT
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
8.3.15. Terumo Corporation Terumo Corporation
8.3.15.1. Company overview
8.3.15.2. Financial performance
8.3.15.3. Product benchmarking
8.3.15.4. Strategic initiatives

List of Tables

Table 1 List of regulatory bodies for different countries
Table 2 Key companies’ product launches
Table 3 Key companies’ merger and acquisitions
Table 4 Key companies’ collaboration
Table 5 Other strategic initiatives of companies
Table 6 North America neuroscience market, by country, 2018 - 2030 (USD Million)
Table 7 North America neuroscience market, by component, 2018 - 2030 (USD Million)
Table 8 North America neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 9 North America neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 10 US neuroscience market, by component, 2018 - 2030 (USD Million)
Table 11 US neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 12 US neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 13 Canada neuroscience market, by component, 2018 - 2030 (USD Million)
Table 14 Canada neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 15 Canada neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 16 Europe neuroscience market, by country, 2018 - 2030 (USD Million)
Table 17 Europe neuroscience market, by component, 2018 - 2030 (USD Million)
Table 18 Europe neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 19 Europe neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 20 UK neuroscience market, by component, 2018 - 2030 (USD Million)
Table 21 UK neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 22 UK neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 23 Germany neuroscience market, by component, 2018 - 2030 (USD Million)
Table 24 Germany neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 25 Germany neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 26 France neuroscience market, by component, 2018 - 2030 (USD Million)
Table 27 France neuroscience market, by Technology, 2018 - 2030 (USD Million)
Table 28 France neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 29 Italy neuroscience market, by component, 2018 - 2030 (USD Million)
Table 30 Italy neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 31 Italy neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 32 Spain neuroscience market, by component, 2018 - 2030 (USD Million)
Table 33 Spain neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 34 Spain neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 35 Norway neuroscience market, by component, 2018 - 2030 (USD Million)
Table 36 Norway neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 37 Norway neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 38 Sweden neuroscience market, by component, 2018 - 2030 (USD Million)
Table 39 Sweden neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 40 Sweden neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 41 Denmark neuroscience market, by component, 2018 - 2030 (USD Million)
Table 42 Denmark neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 43 Denmark neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 44 Asia Pacific neuroscience market, by country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific neuroscience market, by component, 2018 - 2030 (USD Million)
Table 46 Asia Pacific neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 47 Asia Pacific neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 48 Japan neuroscience market, by component, 2018 - 2030 (USD Million)
Table 49 Japan neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 50 Japan neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 51 China neuroscience market, by component, 2018 - 2030 (USD Million)
Table 52 China neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 53 China neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 54 India neuroscience market, by component, 2018 - 2030 (USD Million)
Table 55 India neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 56 India neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 57 Australia neuroscience market, by component, 2018 - 2030 (USD Million)
Table 58 Australia neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 59 Australia neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 60 South Korea neuroscience market, by component, 2018 - 2030 (USD Million)
Table 61 South Korea neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 62 South Korea neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 63 Thailand neuroscience market, by component, 2018 - 2030 (USD Million)
Table 64 Thailand neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 65 Thailand neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 66 Latin America neuroscience market, by country, 2018 - 2030 (USD Million)
Table 67 Latin America neuroscience market, by component, 2018 - 2030 (USD Million)
Table 68 Latin America neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 69 Latin America neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 70 Brazil neuroscience market, by component, 2018 - 2030 (USD Million)
Table 71 Brazil neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 72 Brazil neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 73 Mexico neuroscience market, by component, 2018 - 2030 (USD Million)
Table 74 Mexico neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 75 Mexico neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 76 Argentina neuroscience market, by component, 2018 - 2030 (USD Million)
Table 77 Argentina neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 78 Argentina neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa neuroscience market, by country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa neuroscience market, by component, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 83 South Africa neuroscience market, by component, 2018 - 2030 (USD Million)
Table 84 South Africa neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 85 South Africa neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia neuroscience market, by component, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 89 UAE neuroscience market, by component, 2018 - 2030 (USD Million)
Table 90 UAE neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 91 UAE neuroscience market, by end-user, 2018 - 2030 (USD Million)
Table 92 Kuwait neuroscience market, by component, 2018 - 2030 (USD Million)
Table 93 Kuwait neuroscience market, by technology, 2018 - 2030 (USD Million)
Table 94 Kuwait neuroscience market, by end-user, 2018 - 2030 (USD Million)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 神経科学のグローバル市場2023-2030：機器、消耗品(Neuroscience Market Size, Share & Trends Analysis Report By Component (Instruments, Consumables), By Technology (Neuro-Microscopy, Brain Imaging), By End-user (Hospitals, Diagnostic Laboratories), And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 神経科学のグローバル市場2023-2030：機器、消耗品
  • 世界の医療用チューブ市場2023-2030：シリコーン、ポリオレフィン、ポリ塩化ビニル、ポリカーボネート、その他
  • アテレクトミー装置の世界市場2023-2030：市場規模、シェア、動向分析
  • 生体吸収性冠動脈ステントの世界市場2023-2030：市場規模、シェア、動向分析
  • 処置用トレイの世界市場2023-2030：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆